Skip to main content
Clinical Trials/IRCT20150706023083N3
IRCT20150706023083N3
Recruiting
Phase 3

Comparison of the therapeutic effect of metformin and L-carnitine on ultrasound scoring and liver enzymes in patients with non-alcoholic fatty liver

Tabriz University of Medical Sciences0 sites68 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
non alcoholic fatty liver disease.
Sponsor
Tabriz University of Medical Sciences
Enrollment
68
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age range 18\_65 years old
  • Patients based on ultrasound evidence and testing of non\-alcoholic fatty liver

Exclusion Criteria

  • People under the age of 18
  • Pregnant and lactating women
  • People with kidney failure 30\>GFR
  • People with heart failure HF Class 3 and 4
  • People with liver cirrhosis

Outcomes

Primary Outcomes

Not specified

Similar Trials